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The present study examined physician adherence to clinical practice guidelines (CPG’s). 
CPG’s are a synthesis of the research literature. Successful implementation of CPG’s may 
increase the quality of services delivered. Because youth often present in primary care settings 
with emotional and behavioral problems, CPG’s can help physicians make appropriate decisions 
about the diagnosis and treatment of mental health problems. Building on prior research, the 
present study examined the relative contributions of individual and practice-level knowledge and 
attitudes on pediatrician adherence with the American Academy of Pediatrics guidelines for the 
evaluation, diagnosis and treatment of children with Attention Deficit Hyperactivity Disorder.  
 
Clinical Practice Guidelines 
The Institute of Medicine (IOM) has noted that it takes an average of 17 years to 
incorporate knowledge from randomized controlled trials into practice, and that, even when 
evidence is applied in practice, it is not in a systematic way (Institute of Medicine, 2001). The 
IOM notes that, with respect to treatment of mental health and substance use conditions, there is 
frequently a discrepancy between empirically supported care and the care being delivered 
(Institute of Medicine, 2006). Practical aides, such as clinical practice guidelines (CPG’s) can 
assist in the dissemination of scientific evidence to the professional community and general 
public. Clinical practice guidelines (CPG’s) are “systematically developed statements to assist 
practitioner and patient decisions about appropriate health care for specific clinical 
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circumstances” (Field & Lohr, 1990, p. 38). They represent the synthesis of research findings 
and are designed to support physician utilization of evidence-based practices. Successful 
utilization of CPG’s can help decrease unnecessary, inappropriate variability of services 
delivered (Deutsch, Denton & Borenstein, 1998). The IOM asserted that CPG’s can help ensure 
that scientific evidence is timely, useful and accessible, and results in effective health care 
(Institute of Medicine, 2001).  
CPG’s are available for both physical and mental health practice, although the 
predominance of CPG’s are for physical health. They are developed and/or endorsed by national 
organizations (e.g., Agency for Healthcare Research and Quality; American Academy of 
Pediatrics), state mental health agencies (e.g., Tennessee Department of Mental Health and 
Developmental Disabilities), state Medicare plans, and insurance providers (e.g., Blue Cross 
Blue Shield). CPG’s can be discriminated from practice parameters (PP’s), which are not 
necessarily derived from a systematic review of the empirical literature (Szatmari & March, 
2007). PP’s, such as those developed by the American Academy of Child and Adolescent 
Psychiatry, represent generally accepted practices, rather than standards of care.  
 
Adherence with Clinical Practice Guidelines 
Because of their potential for improving services, and the substantial time, energy and 
money spent developing CPG’s, successful implementation of CPG’s is a major issue. 
Implementation involves actions that translate guidelines into practice, influence physician 
behavior, and encourage physicians to align their practice with guidelines (Cheater & Closs, 
1997). Implementation is typically assessed through the rates of adherence with CPG’s. 
Adherence is primarily evaluated by physician self-report; in rare instances, an independent chart 
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review is conducted. Adherence rates reported in studies are generally not compared to an 
acceptability standard, making interpretation unclear. While some investigators report rates of 
adherence in practice as usual, protocols are often utilized to facilitate implementation and the 
resulting adherence rates are reported (e.g., Leslie, Weckerly, Plemmons, Ladsverk & Eastman, 
2004; Olson, Rosenbaum, Dosa & Roizen, 2005).  
Research suggests that successful implementation of CPG’s may contribute to increased 
quality of medical care and patient outcomes (Brindis & Sennett, 2003). For example, by using a 
two-stage declining effects model (which is similar to growth modeling in hierarchical linear 
modeling), Dennehy et al. (2005) found that increased adherence with the Texas Medication 
Algorithm treatment recommendations was associated with larger decreases in overall 
psychiatric symptoms and depressive symptoms over time in patients with Bipolar Disorder. 
This should not be surprising, given that CPG’s are based on the most current empirical support 
suggesting best practices.  
Despite the potential benefits of adherence, research suggests that CPG’s may be 
infrequently applied in practice (Grol & Buchan, 2006). Accordingly, there appears to be a great 
deal of variability in guideline adherence, depending on the CPG’s under investigation, whether 
all guidelines of interest or only a subset of guidelines are the focus, the medical specialty 
targeted, and the sample utilized. Many studies describing current adherence with CPG’s find 
adherence with some or many of the guidelines (e.g., Broder et al., 2005; Gentile et al., 2004). 
However, few if any physicians in these studies reported adherence with all guidelines. In their 
self-report study, Cheng and colleagues (Cheng, Miller, Ottolini, Brasseux & Rosenquist, 1996) 
found that 22% of physicians reported full adherence with the 1994 American Academy of 
Pediatrics guidelines for tuberculosis testing. Cabana and Flores (2002) cited that, among 
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pediatricians in the United States, only 35% report fully using CPG’s and (except asthma CPG’s) 
no CPG’s are used by more than 27% of pediatricians. Bauer (2002) reviewed studies assessing 
adherence with CPG’s for a variety of mental health and substance conditions published from 
1992 to 2000, and found that only 27% reported adequate adherence. Although poor adherence is 
often cited as a problem in this literature, few meta-analyses describing adherence rates across 
CPG’s could be identified, making it difficult to get an overall sense of physician adherence 
across CPG’s. 
 
Models of Adherence with Clinical Practice Guidelines 
The aforementioned research focuses on adherence as an outcome, without considering 
the process that leads to it. Historically, the active dissemination model was used to explain how 
new medical knowledge affects physician behavior (Pathman, Konrad, Freed, Freeman & Koch, 
1996). This model asserts that information disseminated by respectable sources reliably leads to 
change in physician behavior. Research does not support this overly simplistic model and 
suggests the need for a more complex decision-making model (Pathman et al., 1996; Richens, 
Rycroft-Malone & Morrell, 2004; Solberg et al., 2000). 
Several such models exist, which attempt to describe the internal process leading to 
adherence. Pathman et al. (1996) asserted a phase model in which physicians must: first become 
aware of guidelines, then intellectually agree with the guidelines, then decide to adopt the 
guidelines by following them in practice, and finally adhere to guidelines by successfully 
utilizing them when appropriate. This model follows in the tradition of the transtheoretical model 
of change, which suggests that individuals make change intentionally as a result of proceeding 
through the stages of change (Prochaska and DiClemente, 1983).  Although Pathman and 
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colleagues found some support for their model, physician behavior did not always follow the 
phases sequentially. This is illustrated by their finding that 11% of physicians followed 
guidelines despite not agreeing with them. The assertion that physician adherence behaviors 
must follow a stepwise path seems too restrictive and does not adequately capture the complex 
decision making process that leads to physician behavior.  
Cabana et al. (1999) offer an alternative model of adherence. They conducted a review of 
studies examining barriers to adherence and found that identified barriers related to knowledge, 
attitudes and external characteristics. “Cognitive” barriers included lack of awareness or 
familiarity with the CPG’s. “Affective” barriers included a lack of: agreement with CPG’s, 
motivation, self-efficacy, or outcome expectancy. “Behavioral” barriers included characteristics 
of the patients, guidelines, and environment. Cabana and colleagues found that knowledge and 
attitude barriers were cited twice as often as external barriers to adherence. This model asserts 
knowledge, attitudes and external characteristics as potential mechanisms of action leading to 
adherence or non-adherence. This model also suggests a sequence leading to behavior change, 
with CPG’s first affecting knowledge, then attitudes before affecting behavior, although 
proceeding through this sequence is not a necessary precursor to behavior change. Like social 
cognitive theory (e.g., Bandura, 1977), this model emphasizes the impact of outcome 
expectancy, self-efficacy, and the environment on behavior change. Cabana et al. reported on the 
frequency with which barriers were reported by physicians, but did not relate these frequencies 
to adherence rates. Cabana, Rushton and Rush (2002) applied this model to adherence to the 
CPG’s for depression and cited multiple physician knowledge, attitude and external barriers to 
following guidelines. However, they focused on reviewing these barriers, rather than empirically 
testing their model.  
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Support for Relationship between Physician and Practice Characteristics and Adherence 
Studies exploring adherence with CPG’s in specific areas of medicine may supplement 
the model proposed by Cabana et al. (1999). The majority of studies focus on adherence with 
physical health rather than mental health guidelines. Familiarity with and knowledge of CPG’s 
has repeatedly been linked to increased adherence. Cheng and colleagues (Cheng, Miller, 
Ottolini, Brasseux & Rosenquist, 1996) found that, when entered into a logistic regression, 
awareness of AAP tuberculosis testing guidelines was most predictive of adopting those 
guidelines. With respect to adherence with pharmacotherapy guidelines for hypertension, 
physicians with knowledge of best practices were more likely to select the correct treatment 
option in a vignette (Nelson, Reid, Krum & McNeil, 2003).  
However, the relationship between familiarity and adherence varies, based on the CPG’s 
investigated. For example, in Ward et al.’s study (2002) targeting adherence with the Agency for 
Health Care Policy and Research smoking cessation guidelines, the majority of physicians 
reported practices consistent with adherence despite the fact that 44% of physicians reported 
little or no familiarity with the guidelines. Given that the sample was drawn from Veterans 
Health Administration facilities, where smoking cessation is frequently a goal of treatment, 
physicians likely already had the requisite knowledge about smoking cessation, making the 
guidelines less salient. This suggests that familiarity with guidelines may not be critical to 
adherence when guidelines are intuitive or represent behaviors physicians are already doing.  
Related to research on familiarity and adherence are studies examining academic 
detailing and other education-based interventions. Academic detailing involves having a credible 
expert deliver key information about evidence based practice to an individual or group of 
providers, typically in their own office. Because these interventions aim to change physician 
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behavior by targeting knowledge, they are relevant to the current discussion. Results of these 
studies are mixed. Some research suggests that academic detailing is an effective way of 
improving CPG implementation (e.g., Avorn & Soumerai, 1983; Davis & Taylor-Vaisey, 1997; 
May, Rowett, Gilbert, McNeece & Hurley, 1999). Lu and colleagues (Lu, Ross-Degnan, 
Soumerai, & Pearson, 2008) reviewed studies on improving medication management and found 
that disseminating educational materials was not a sufficient strategy, but one-on-one academic 
detailing was. Some studies suggest mixed findings (e.g., Chaillet et al, 2006), while others 
indicate it is not an effective implementation intervention (e.g., Simon, 2002; Witt, Knudsen, 
Ditlevsen & Hollnagel, 2004). Taken together, this research indicates that although knowledge is 
linked to physician adherence behavior, the process of changing physician behavior is complex.  
Physician attitudes have also been tied to adherence; here, “attitudes” include thoughts, 
beliefs and perceptions about: the disease or problem, its assessment and treatment; external 
barriers (e.g., time constraints on practice); specific CPG’s; CPG’s in general; and patient 
receptiveness toward physician recommendations. Examples of studies focusing on each of these 
relationships are shown in Table 1. In these studies, more negative attitudes were consistently 
associated with poorer adherence. 
 
Table 1. Studies Linking Physician Attitudes to Adherence. 
 Type of Attitude Study 
Perceived external barriers Gentile et al., 2004 
Negative attitudes toward CPG’s  Foley, Vasey, Alexander & Markson, 2003 Ubel, Jepson & Asch, 2003 
Lack of agreement with CPG Cabana et al., 2000 
General attitudes/beliefs about guidelines Flores, Lee, Bauchner & Kastner, 2000 
Beliefs about patient receptiveness to 
recommendations 
Gentile et al., 2004 
Vaughn et al., 2002 
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Physician demographic variables have also been linked to adherence. Gender has been 
associated with adherence, with female physicians demonstrating increased adherence (e.g., 
Broder et al., 2005; Ely et al., 1998; Gentile et al., 2004). In addition, physician specialization 
has been repeatedly linked with adherence. This is especially evident in the pediatric literature, in 
which pediatricians are consistently more adherent with pediatric CPG’s than family physicians 
(e.g., Cheng et al., 1996; Pathman et al., 1996). 
Although individual characteristics such as knowledge and attitudes are tied to adherence, 
they are not necessarily sufficient preconditions for adherence (Cabana et al., 1999). The context 
which physicians practice in can also influence their adherence to CPG’s. Contextual variables 
include organizational characteristics, such as supportive leadership, having strategic plan for 
implementation, and capability and culture for continuous quality improvement (Solberg et al., 
2000). Although such organizational characteristics are asserted to influence physician practices 
and adherence behaviors, empirical research linking these characteristics to individual physician 
adherence is lacking.  
Because individual-level knowledge and attitudes impact adherence, it follows that the 
overall knowledge and attitudes of physicians within a practice may influence adherence of 
physicians in that practice. Such practice-level internal characteristics represent additional 
contextual variables that may relate to adherence. Surprisingly, no studies were identified which 
explored these relationships, which suggests a gap in the research literature. 
Finally, in terms of other factors that may impact physician adherence, there is a limited 
amount of research on the relationship between patient characteristics and physicians’ diagnosis 
and treatment practices. There are mixed findings regarding the relationship between patient 
demographics (e.g., age, gender, and ethnicity) and physician adherence. For example, Dennehy 
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et al (2005) did not find a significant relationship between patient demographics and physician 
adherence with the Texas Medication Algorithm. 
 
Attention Deficit Hyperactivity Disorder 
 Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed 
behavioral disorder of childhood. Prevalence rates of ADHD in school-age children range from 
2% to 18% in community samples (Rowland, Lesesne & Abramowitz, 2002). Visser and Lesesne 
(2005) found that 7.8% of parents of school-aged children were reported that their children had 
ADHD. Individuals with ADHD experience marked difficulties with attention, impulsiveness, 
and/or hyperactivity. While some youth with ADHD may experience a combination of these 
symptoms (Combined Type), others may experience a predominance of attention difficulties 
(Inattentive Type) or difficulties with impulsivity and hyperactivity (Hyperactive-Impulsive 
Type). Other youth may experience symptoms of inattention or hyperactivity/impulsivity, but do 
not meet full criteria for one of the three aforementioned ADHD Diagnoses (ADHD Not 
Otherwise Specified, or ADHD NOS) (American Psychiatric Association, 2000). Clinically, 
ADHD NOS is frequently used as a preliminary ADHD diagnosis while additional information is 
being gathered. Currently, assessment of ADHD involves the use of parent, teacher and/or youth 
interviews, responses to rating scales, and behavioral observations. ADHD is most often treated 
using medication (primarily stimulants in youth), behavior therapy or a combination thereof. 
Although recent research suggests that the diagnosis of ADHD is likely to be initially 
suggested by teachers (Sax & Kautz, 2003), youth with ADHD are evaluated and treated in a 
variety of settings. While school psychologists, counselors, clinical psychologists and 
psychiatrists may all be involved in caring for youth with ADHD, most children with ADHD are 
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treated by neurologists and primary care physicians (Zarin, Suarez, Pincus, Kupersanin & Zito, 
1998). Given that ADHD is typically diagnosed in children and young adolescents (between 6 
and 12 years old), pediatricians are particularly important in evaluating and treating ADHD in 
primary care.  
 
American Academy of Pediatrics Clinical Practice Guidelines for ADHD 
 Because primary care physicians—particularly pediatricians—are integral in the 
assessment and treatment of youth with ADHD, it is critical that they are aware of best practices. 
However, many physicians do not receive specialized training in managing emotional and 
behavioral disorders (EBD’s). This may lead to considerable variability in the evaluation and 
treatment of EBD’s, such as ADHD. To combat this and provide physicians with evidence-based 
recommendations, the American Academy of Pediatrics (AAP) developed CPG’s for the 
evaluation and treatment of youth with ADHD. 
 The AAP developed these guidelines through collaboration among individuals from 
various primary care and subspecialty groups. Chosen individuals formed a subcommittee, which 
met over a 3-year period to review the medical, psychological and educational literature and 
determine the practices for which the best empirical support exists. Relevant empirical studies 
were obtained, reviewed, and summarized, which led to the development of draft practice 
guidelines. These drafts were subjected to internal and external review, and subsequent revisions. 
The results of this process were two clinical practice guidelines: the evaluation and diagnosis 
guideline (American Academy of Pediatrics, 2000) and the treatment guideline (American 
Academy of Pediatrics, 2001). Strength of evidence for each recommendation is included with 
the guidelines. Evidence for the evaluation and diagnosis recommendations is rated as good, 
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while evidence for the treatment recommendations ranges from weak to good. Despite the 
variable strength of empirical support for recommendations, all recommendations in both CPG’s 
were strongly recommended. 
 Descriptive studies suggest that physicians practicing as usual (i.e., without the aid of an 
implementation intervention) vary in terms of their adherence to the AAP ADHD guidelines. 
Rushton, Fant and Clark (2004) found that self-reported overall adherence with evaluation and 
treatment guidelines ranged from 39% among family physicians to 78% among pediatricians. 
They found that 14% of family physicians and 35% of pediatricians self-reported using all 
evaluation guidelines. Chan, Hopkins, Perrin, Herrerias and Homer (2005) found that only 8% of 
their sample reported evaluation practices consistent with four of the six AAP guidelines. Self-
reported adherence to specific evaluation guidelines reportedly varies between 40 and 96% 
depending on the guideline and sample (Daly, Rasmussen, Agerter & Cha, 2006; Rushton et al., 
2004). Using chart audits, Epstein and colleagues (2008) found that adherence to specific 
evaluation guidelines ranged from 38% to 55%, while adherence to specific treatment guidelines 
ranged from 9% to 52%. Rushton et al. found that adherence to specific treatment guidelines 
ranged from 52 to 81% depending on the guideline. All aforementioned studies except the study 
conducted by Epstein and colleagues used physician self-report to determine adherence rates, 
rather than independent chart review. 
Results of empirical studies investigating adherence to the AAP ADHD guidelines 
suggest that increased familiarity with the guidelines has been linked to better adherence 
(Lanham, 2006). Although physicians in several studies reported perceived barriers to using the 
AAP ADHD guidelines, the relationship between barriers and adherence was not explored. 
Likewise, basic practice-level characteristics (e.g., type of practice) were reported but not 
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empirically examined. No studies exploring the connection between youth or physician 
descriptive characteristics and adherence with the AAP ADHD guidelines were identified. 
Despite the lack of research exploring what may affect AAP ADHD guideline adherence, many 
investigators utilized interventions to increase adherence rates.   
 
The Present Study 
 Reviewing the literature reveals several weaknesses of research on physician adherence 
to CPG’s. First, while some basic research has been conducted that describes adherence rates in 
treatment as usual, there is inconclusive knowledge about overall adherence rates, variables 
associated with adherence, and impact of adherence on patient outcomes. In addition, while some 
models of physician behavior change have been asserted, they have not generally been linked to 
empirical studies. Pursuing more foundational research on physician adherence and the factors 
that may affect adherence is a logical next step for research in this area, to ensure that 
interventions, when developed, will be appropriate and more likely to be effective.  
Because CPG’s may have the greatest impact when they address practices outside of 
physicians’ existing knowledge and training, examining adherence to CPG’s addressing 
emotional and behavioral disorders could prove beneficial. Because ADHD is frequently 
assessed and treated in primary care, understanding adherence to the AAP ADHD guidelines can 
provide insight into these important physician mental health care practices. However, few studies 
in this area explore the factors associated with adherence without the aid of an implementation 
intervention. Basic research investigating physicians’ practice as usual with regard to the AAP 
ADHD guidelines could serve as a foundation, to determine if such interventions are necessary 
and, if so, what to target with interventions. 
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Studies focusing on physician adherence largely do not hypothesize about the pathway 
leading to physicians’ adherence behaviors. Rather, they assert that physicians frequently do not 
provide evidence-based care in part because of barriers or because they do not have a systematic 
way of implementing guidelines, and target these variables with interventions. Cabana et al. 
(1999) provide one model of how physician knowledge and attitudes interact with external 
characteristics to determine physician adherence, but this model has not been empirically tested. 
In addition, although differences in adherence based on physician descriptive characteristics 
(e.g., female physicians being more adherent, as previously described) have been found in 
multiple studies, these findings have not been examined in great detail to help understand why 
they exist. 
The methods utilized in studies of physician adherence are also lacking. Familiarity with 
CPG’s is often equated with knowledge about CPG’s. However, familiarity may capture 
something different, since knowledge can be objectively measured whereas familiarity (as 
assessed here) is a subjective measure. In addition, most studies use physician self-report to 
determine their adherence with CPG's. Chart reviews are rarely used, despite the fact that they 
provide more objective descriptions of physician behavior (e.g., Montaño & Phillips, 1995). 
Finally, analysis methods for investigating physician adherence are generally simplistic and 
unable to answer more complex questions addressing relationships between adherence and 
characteristics at multiple levels (i.e. physician level, practice level).  
Based on these weaknesses in the literature, the present study addressed the 
characteristics that affect pediatrician adherence to the AAP ADHD guidelines. Because 
empirical research suggests that both physician knowledge and attitudes are connected to 
physician adherence, these characteristics were be investigated. While the majority of studies 
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investigating the relationship between adherence and practice-level characteristics have focused 
on organizational qualities, the present study took an alternative approach, focusing instead on 
the practice-level knowledge and attitudes of physicians. In addition, the present study improved 
on the measurement and analysis of prior research by: assessing objective knowledge rather than 
subjective familiarity, utilizing chart review data to assess adherence, and using analyses that 
will adequately capture the multi-level nature of the data being used. Thus, understanding the 
relative contributions of individual and practice-level knowledge and attitudes on pediatricians’ 
adherence to the AAP ADHD guidelines were pursued in the present investigation. The 
following research questions were addressed:  
1. Based on prior significant findings as well as the conceptual model asserted by Cabana 
and colleagues (1999), the prediction of physician adherence by knowledge and attitudes 
will be examined. Thus, the first research question is: do greater knowledge and more 
positive attitudes predict increased physician adherence with AAP ADHD guidelines?  
2. The present study will also examine the context within which pediatricians practice. 
Because of the empirical link between adherence and knowledge and attitudes at the 
individual level, knowledge and attitudes across the pediatricians within the individual’s 
practice will also be examined.  Thus, the second research question is: do greater 
practice-level knowledge and more positive practice-level attitudes predict increased 
adherence with AAP ADHD guidelines?  
3. Because multilevel modeling will be used, it will be possible to simultaneously examine 
the predictive value of individual pediatrician and practice-level characteristics. Thus, the 
third research question to this is: what are the relative contributions of individual 
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physician and practice-level knowledge and attitudes on physician adherence with AAP 
ADHD guidelines?  
4. Prior descriptive studies examining adherence with the AAP ADHD guidelines have 
found that adherence varies depending on which type of adherence (overall, evaluation or 
treatment) or what specific guideline is being examined. Thus, the current study will 
examine these three types of adherence in separate multilevel models to answer the 
question: do individual and practice-level knowledge and attitudes predict adherence 
differently based on the guidelines (i.e., overall guidelines versus evaluation guidelines 
versus treatment versus guidelines)?    
5. Based on the literature examining adherence with guidelines, it is evident that gender 
may be related to adherence. The present study will examine the prediction of adherence 
by gender and age, answering the question: does the prediction of adherence vary based 
on physician descriptive characteristics? In particular, do female pediatricians have 
higher rates of adherence?  
6. Although there is not strong research supporting the relationship between youth 
characteristics and adherence, youth characteristics such as specific ADHD diagnosis, 
youth age and gender provide an additional context for pediatricians’ practice behavior 
and as such will be examined. Thus, the next research question being examined is: does 
the prediction of adherence by knowledge and attitudes vary based on youth descriptive 
and diagnostic characteristics?  
7. Given that there are some issues related to timing—both in terms of the data being 
collected in two phases and in terms of the timing of the release of guidelines compared 
to data collection—it was important to look at the effect of timing on adherence. Thus, 
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the final research question being examined is: does the prediction of adherence vary 







Purpose of Original Study 
 The present study is a secondary data analysis of an existing data set (Center for 
Evaluation and Program Improvement, 2007). The primary study was focused on first describing 
pediatricians’ diagnosis and treatment of ADHD and their adherence with the AAP ADHD 
guidelines, and then examining the effects of a brief intervention on adherence behaviors. The 
intervention was developed in response to the National Advisory Mental Health Council’s 
challenge to develop reasoned methodology to promote clinical guideline utilization (National 
Institute of Mental Health, 1998). The intervention was intended to educate and motivate 
physicians in order to increase compliance with the AAP ADHD guidelines (Center for 
Evaluation and Program Improvement, 2007). Ongoing approval from the Institutional Review 
Board was obtained for the original study. 
 
Participants 
Participants were 78 pediatricians and 749 of their patients with ADHD from 18 
independent practices in the metropolitan Atlanta area. Participating pediatricians and their 
practices were part of a network of providers dedicated to improving the quality of office-based 
pediatric healthcare. The pediatrician sample was 59% male. The pediatriciansample was 90% 
Caucasian, 4% African American, 5% Asian and Pacific Islander, 5% Hispanic1 and about 1% 
                                                 
1 Because participants could indicate their race as well as their ethnicity (whether they were of Spanish/Hispanic 
origin), the total sample race and ethnicity adds up to greater than 100%. 
  18
other (self-identified). Average age of the pediatrician sample was 45.4 years (SD = 8.92). The 
average practice was 67% male, was 94% Caucasian and about 6% Asian, and was composed of 
pediatricians with an average age of 47.98 (SD = 8.23). There were an average of approximately 
4 pediatricians in each practice (mean = 4.33).   
Based on chart review, descriptive information was obtained about the sample of patients. 
Patients were 69% male with an average age of 12.6 years (SD = 2.71). Racial and ethnic 
information was not included in 50% of the charts, so were not available for analysis. With 
respect to ADHD diagnosis, 25.2% of the patients were diagnosed with ADHD Inattentive Type, 
5.5% were diagnosed with ADHD Hyperactive-Impulsive Type, 17.8% were diagnosed with 
ADHD Combined Type, and 51.5% were diagnosed with either an unspecified ADHD diagnosis 
or with ADHD Not Otherwise Specified. 
 
Procedures 
To conduct the primary study, Vanderbilt University partnered with a large network of 
primary care pediatricians. The network was created to integrate clinical and financial practice 
through quality management, managed care contract participation, and linked electronic 
information systems. The project was endorsed by the directors of the network and advertised to 
all pediatricians within the network. Pediatricians were then mailed introductory information 
about the study and were asked to complete a background survey to help describe the population 
from which the sample was drawn. The introductory packet also contained the consent form and 
a more specific background survey, both of which were completed by pediatricians interested in 
participating in the study. A third background survey assessing practice characteristics was 
simultaneously sent to a Key Staff Person (KSP) in the pediatricians’ office and was completed 
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if pediatricians chose to participate in the study. The pediatrician questionnaires used in the 
present study came from baseline data collection and were completed between June of 2001 and 
February of 2002.  
Physician adherence with the AAP ADHD guidelines was assessed through independent 
chart reviews. KSP’s at each participating practice reviewed charts to determine eligibility for 
study participation. For charts to be eligible, youth must have been diagnosed with ADHD 
between the ages of 6 and 18 years. Youth had to be diagnosed by a participating pediatrician or 
someone the pediatrician referred the youth to for diagnosis (e.g., psychiatrist, psychologist, 
neurologist). Charts for youth who had been diagnosed within 6 to 24 months were preferable, as 
were charts for youth who had been in treatment for 12 months or more. However, when a 
sufficient number of charts meeting these criteria were not identified, the length of treatment 
criteria was relaxed. Multiple charts were selected for each physician (mean number of charts per 
physician = 9.85). After KSP’s selected eligible charts, each chart was redacted, and the 
anonymous charts were then sent to the research team for auditing.  
Because of the goals of the primary study, the chart audit data used in the present study 
were collected in two waves- at baseline (pre-intervention) and post-intervention. Charts were 
collected on different patients at each wave. Three hundred and thirty-five baseline charts were 
collected from October of 2001 till September of 2002. The intervention phase of the study 
began in February of 2002 and ended in February of 2003. Four hundred and fourteen post-
intervention charts were collected from June of 2005 to April of 2006. Analyses from the 
primary study indicated that there were no effects of the intervention; thus data will be used that 
were collected both pre- and post-intervention (additional discussion about ruling out wave 
effects is included in the analysis plan). An additional time-related issue is the release of the 
  20
AAP ADHD guidelines; diagnostic guidelines were published in May of 2000, while treatment 
guidelines were published in October of 2001.  
 
Measures 
I. Pediatrician Background Questionnaire (for copies of relevant questionnaires included in the 
Pediatrician Background Questionnaire, see Appendix A) 
 Background and Demographics. Participating pediatricians were asked to provide basic 
demographic information (e.g., age, gender, racial/ethnic background). In addition, they reported 
on background characteristics relevant to their training as a physician and their current practice. 
 Knowledge. Pediatricians completed a 66-item Knowledge Questionnaire (Center for 
Evaluation and Program Improvement, 2000) assessing their knowledge of the best practices 
when evaluating and treating ADHD. Items were designed to capture the recommendations made 
in the AAP ADHD guidelines. Specific items addressed issues such as screening for comorbid 
conditions, DSM-IV criteria for ADHD, behavior therapy and medication management for 
ADHD. The majority of items are rated true or false, with two items scored rated on a 4-point 
scale. Higher scores indicate more knowledge about the content of the AAP ADHD guidelines.  
 Attitudes. Pediatricians’ perceived barriers to better ADHD care were assessed using an 
eighteen-item Perceived Barriers Questionnaire (Center for Evaluation and Program 
Improvement, 2000). Pediatricians reported on various internal (e.g., insufficient knowledge and 
skills) and external (e.g., not enough time) barriers to better ADHD assessment and treatment. 
Pediatrician responses were made on a 5-point scale (0-4 scale), with higher scores indicating a 
higher level of perceived barriers. Internal consistency of the Perceived Barriers Questionnaire 
was .83 in the present sample. Part-whole correlations indicated that six items had low 
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correlations with the measure and thus were eliminated. Coefficient alpha was recalculated for 
the revised twelve item Perceived Barriers Questionnaire (PBQ-R) and was .85, which indicates 
good reliability. Physician responses to the revised twelve item measure were subjected to 
exploratory factor analysis with promax rotation to allow correlations between factors. Results 
suggested that the items were best captured by a one-factor structure, which accounted for 39% 
of the variance. In addition, Kaiser’s mean sampling adequacy (MSA) was investigated to assess 
whether the items fit a common factor model; overall MSA of .79 suggests that the items 
measure a common factor. 
  The fourteen-item Physician Belief Scale (PBS; McLennan, Jansen-McWilliams, Comer, 
Gardner & Kelleher, 1999) was used to assess pediatricians’ beliefs about psychosocial aspects 
of their work with patients. Items address pediatricians’ thoughts about providing psychosocial 
care to their patients, as well as what physicians perceived their patients’ and caregivers’ 
thoughts were about receiving psychosocial care from their pediatrician. Pediatricians rated 
responses on a 5-point scale (1-5 scale); higher scores indicate more negative attitudes toward 
providing psychosocial care. McLennan et al. found coefficient alphas between .75 and .81, 
suggesting adequate internal consistency. The PBS was modified slightly for the present study, 
with the order of items slightly changing and one additional item being added. Internal 
consistency for the revised PBS (PBS-R) in the current sample was .88, which indicates good 
reliability. The part-whole correlations indicated moderate to large correlations among items. 
Physician responses were subjected to exploratory factor analysis with promax rotation. Results 
suggested that the items were best captured by a one-factor structure, which accounted for 41% 
of the variance. Overall MSA was .85, which suggests that the items measure a common factor. 
The PBS-R is mildly correlated with the PBQ-R in the present sample (r = .26, p < .05). 
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II. Pediatrician Chart Audit (for copies of the Summary Chart Audit Form, see Appendix B) 
 Adherence. Anonymous charts were audited to determine pediatricians’ adherence to each 
recommendation of the AAP ADHD guidelines. Several challenges of using chart data were 
evident and were taken into account when determining adherence. First, it would be virtually 
impossible for an independent reviewer to determine whether or not some specific AAP ADHD 
recommendations were being followed. For example, Recommendation 6 of the AAP ADHD 
Evaluation guidelines specifies that other diagnostic tests should not be routinely used to 
diagnosis ADHD (e.g., laboratory tests). However, because reviewers did not have complete 
knowledge of each case, they could not establish whether or not laboratory tests requested were 
requested solely for ruling out ADHD (i.e., perhaps the child needed the laboratory tests for 
another reason). Challenges such as this led to the exclusion of three evaluation 
recommendations and two treatment recommendations (see Appendix B for list of 
recommendations and rationale for exclusion, when applicable). 
 Each remaining recommendation was utilized as criteria for the chart audit (Center for 
Evaluation and Program Improvement, 2000; see Appendix B for a copy of the Summary Chart 
Audit rating system). Recommendations were operationalized into concrete actions and 
categorized into components. Raters were then trained to the criteria, and underwent periodic 
retests to minimize drift. Charts were then assessed for completeness of necessary information. 
For example, Recommendation 2 of the AAP ADHD Evaluation guideline specifies that all 
DSM-IV criteria be used in diagnosing ADHD. To evaluate adherence to that recommendation, 
physicians’ attention to symptoms, functional impairment, age of onset, and use of rating scales 
were all necessary for pediatricians to be rated as adherent to that recommendation. Pediatricians 
were thus rated on each component within a recommendation. Each chart was independently 
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reviewed by two trained auditors. Auditors then met to come to a consensus on the ratings; the 
consensus data comprises the chart audit data used in the present study. Final ratings were then 
summed and adherence scores were calculated for each chart. Higher positive scores indicate 
more adherence to the AAP guidelines. Separate adherence scores were calculated for overall 
adherence (with all AAP ADHD guidelines), and the evaluation and treatment guidelines.  
 Youth Background and Demographics. From each chart, youth age and gender were 
collected. In addition, the youth’s specific ADHD diagnosis (Hyperactive-Impulsive Type, 
Inattentive Type, Combined Type, Not Otherwise Specified) was included.  
 
Data Analysis 
Prior to conducting the primary analyses of the study, a power analysis was calculated to 
ensure adequate ability to detect significant effects (see Appendix C). Following this, descriptive 
analyses of study variables at each level of data were conducted. Overall physician adherence as 
well as adherence with the evaluation and treatment guidelines was examined, to determine 
which statistical procedure should be used to for modeling. Responses to the knowledge and 
attitudes measures were also examined. Results of these basic descriptive analyses are presented 
before results of the primary analyses. 
Because the data for the present sample are nested—charts within pediatricians within 
practices—multilevel modeling (MLM) was used to test the main research questions. The 
present data can be best described by the classic Singer (1998) school effects model, in which the 
data are at multiple levels within an organizational hierarchy, and one wishes to examine a 
dependent variable at a particular level as a function of predictors at various levels. The random 
effects within the multilevel model describe the variability in the dependent variable between 
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(i.e., specified random effects) and within (i.e., residual) each specified level.  The fixed effects 
represent the predictor variables at each level; that is, fixed effects describe the relationship 
between the independent variables and dependent variable. Thus, MLM makes it possible to 
control for the variance accounted for by each nesting level and examine adherence as a function 
of individual and practice level knowledge and attitudes. 
The SAS PROC MIXED procedure was used for multilevel modeling. A series of models 
were fitted to determine which model accounted for the most variance and was most 
parsimonious (Singer & Willett, 2003). Chart audit data represent level 1, individual 
pediatricians represent level 2, and practice level data represent level 3. Chart level adherence 
was used as the dependent variable, to capture the variation in adherence across charts. Separate 
models were specified for overall adherence, adherence to evaluation guidelines, and adherence 
to treatment guidelines. To account for the effect of pediatrician and practice level clustering on 
adherence, Levels 2 and 3 were specified as random effects. Knowledge and attitudes were 
predictor variables specified as level 2 and 3 fixed effects. Level 1, 2 and 3 descriptive 
characteristics2 (youth and physician gender and age), as well as specific youth ADHD diagnosis 
(Hyperactive-Impulsive Type, Inattentive Type, Combined Type, and NOS/Unspecified) were 
included as additional fixed effects to determine whether the prediction of adherence varies 
based on different levels of these characteristics.  
 Based on Singer’s analysis suggestions (1998) and later recommendations from Singer and 
Willett (2003), the unconditional means model was the initial model tested. It includes level 2 
and 3 random effects, but no predictors; only the intercept predicts adherence in this model. The 
unconditional means model is the baseline against which substantive models can be compared. 
The random effects (covariance parameter estimates) were examined to determine whether 
                                                 
2 Pediatrician and youth race and ethnicity were not included in the modeling due to missing data. 
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variance components statistically differ from 0. This establishes how much variance in adherence 
is accounted for by the systematic variation (i.e., clustering) between pediatricians and between 
practices. If random effects were significant, they remained in subsequent models to control for 
this clustering. 
 Next, separate models specifying only level 1, 2 or level 3 predictors were tested. The 
relationship between specified random effects and the outcome were examined. The relationship 
between each fixed effect and the outcome was examined to test for main effects. Examining 
these relationships helped establish how much variation is explained by the addition of each 
fixed effect and how much continued to be explained by the specified random effects. A 
multilevel model including all significant predictors and significant random effects at each level 
was then specified. Relative goodness of fit of each model was established. Because the data 
were collected in two waves, time represents a threat to validity of the current study. To follow-
up on this, an additional model for each adherence variable was tested for significance, which 
included wave as a fixed effect. The best fitting, most parsimonious model was retained for each 








 Pediatrician Knowledge and Attitudes. Physicians varied in their knowledge of best 
practices for evaluation and treatment of ADHD (see Table 2), with the average score on the 
Knowledge Questionnaire being 83%. By sorting the data by practice, the knowledge of 
pediatricians within practices was examined. Results indicate that while the average physician 
and practice level scores on the Knowledge Questionnaire were the same, there was greater 
variation in individual pediatricians’ knowledge of best practices.  
Results suggest that individual pediatricians vary widely in their perception of barriers to 
their providing better ADHD care (see Table 2). While the mean score on the PBQ-R was 1.4, 
indicating that the average amount of barriers endorsed is about 35%, some pediatricians 
perceive very few barriers to their providing better care while others perceive many barriers. As 
seen in Table 2, the average practice endorsed slightly fewer perceived barriers to providing 
better ADHD care, with practices being slightly less variable in perceived barriers than 
individual pediatricians. 
Physicians had generally positive attitudes toward providing psychosocial care, as 
evident in responses on the PBS-R. The mean score on the PBS-R was 2.17, indicating that 
physicians endorsed an average of 29% of the possible negative attitudes toward providing 
psychosocial care. As evident in Table 2, some physicians had very positive attitudes toward 
providing psychosocial care while others had somewhat negative attitudes. The average practice 
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endorsed slightly more negative attitudes than the average physician, with the range of practice 
scores on the PBS-R being slightly smaller and more negative. 
 
Table 2. Knowledge and Attitudes Scores at Pediatrician and Practice Levels. 
 
 
 Adherence with AAP ADHD Guidelines. Adherence with the AAP ADHD guidelines 
varied based on the type of guideline (see Table 3). Across all 749 charts, the average adherence 
with all guidelines (i.e., overall adherence) was 58%. There was a wide range of overall 
adherence, with some charts having very poor adherence and some having near perfect 
adherence. The average adherence with evaluation guidelines across charts was much higher 
(85%), with the majority of charts having high to near perfect in adherence. With respect to 
treatment guidelines, the average adherence was quite low (37%), with most charts having low to 
                                                 
3 For Knowledge Questionnaire, higher percentage indicates more knowledge. For PBQ-R, higher percentage 
indicates higher perception of barriers. For PBS-R, higher percentage indicates more negative attitudes. 
Measure Scale N Mean/Percent3 SD Min Max 
Pediatrician Level (Level 2)        
Knowledge Questionnaire 0-66 75 54.83 (83%) 4.86 42 (63%) 64 (97%) 
Attitude Measures            
     Perceived Barriers  
     Questionnaire- Revised 
0-4 78 1.40 (35%) 0.57 0.25 (6%) 2.55 (63%) 
     Physician Belief Scale-  
     Revised 
1-5  75 2.17 (29%) 0.54 1.13 (3%) 3.31 (58%) 
Practice Level (Level 3)       
Knowledge Questionnaire 0-66 16 54.81 (83%) 4.59 48 (72%) 62 (94%) 
Attitude Measures            
     Perceived Barriers  
     Questionnaire- Revised* 
0-4 18 1.27 (32%) 0.54 0.33 (8%) 2.42 (61%) 
     Physician Belief Scale-  
     Revised* 
1-5  16 2.19 (30%) 0.53 1.33 (8%) 3.31 (58%) 
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moderate adherence. Graphs illustrating the distribution of each adherence score are presented in 
Appendix D. 
 









 Overall Adherence. The unconditional means model was fit first (Table 4). This model 
revealed significant variation between pediatricians and between practices4, which indicates the 
need to include both random effects in subsequent models. The intraclass correlation coefficient 
was .11, indicating that a moderate amount of variance in adherence was due to clustering (Hox, 
2002). The Pearson correlation assessing the relationship between the predicted and observed 
adherence was .41 (p < .001), which suggests a moderate relationship. 
 By following the previously described stepwise process, a parsimonious substantive model, 
including significant random and fixed effects at all levels, was derived (Table 5). Wave of data 
collection was not a significant predictor of adherence, and was thus not included in the final 
model. When simultaneously entered with fixed effects, there continued to be significant 
variation in overall adherence between pediatricians. Results indicate a main effect for youth 
                                                 
4 Because adherence is assessed on a 0-1 scale, all estimates are given out to 3 decimal places. 
Adherence N Mean/ 
Percent 
SD Min Max 
Overall Adherence 749 0.58 (58%) 0.12 0.14 0.96 
Adherence with Evaluation Guidelines 749 0.85 (85%) 0.22 0.00 1.00 
Adherence with Treatment Guidelines  749 0.37 (37%) 0.13 0.00 0.75 
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age, such that the older the patients were, the less adherent physicians were with the overall 
guidelines (see Figure 1). In addition, there was a main effect of youth diagnosis on overall 
adherence (see Figure 2). Pediatricians were significantly more adherent with the overall 
guidelines for youth diagnosed with ADHD Inattentive Type or ADHD Combined Type as 
compared to youth diagnosed with ADHD NOS/Unspecified Type. The Pearson correlation 
between the observed and predicted adherence for the multilevel model was .50 (p < .001), 
indicating a moderate to strong relationship, and an improvement over the unconditional means 
model. 
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Table 4. Unconditional Means Models Predicting Overall, Evaluation and Treatment Adherence. 
* p < .05, ** p < .01, *** p < .001 
 
Table 5. Final Multilevel Models Predicting Overall, Evaluation and Treatment Adherence. 
 Overall Adherence Evaluation Adherence Treatment Adherence 
Random Effects Estimate SE z Estimate SE z Estimate SE z 
Pediatrician  .002 .001 2.97* .006 .002 3.63*** ----- ----- NS 
Residual .012 .001 15.42*** .039 .002 18.28*** .018 .001 16.60*** 
Fixed Effects Estimate SE t Estimate SE t Estimate SE t 
Intercept .611 .024 25.35*** .799 .014 57.76*** .500 .035 14.43*** 
Practice Level 
Perceived Barriers 
----- ----- ----- ----- ----- ----- -.048 .015 -3.18* 
Youth Age -.004 .002 -2.42* ----- ----- ----- -.005 .002 -2.40* 
Youth Diagnosis    
    Combined Type .052 .013 3.90** .123 .021 5.77*** ----- ----- NS 
    Inattentive Type .037 .012 3.17* .103 .019 5.58*** ----- ----- NS 
Hyperactive-
Impulsive Type 
.042 .022 NS .043 .033 NS ----- ----- NS 
* p < .05, ** p < .01, *** p < .001 
 
 Overall Adherence Evaluation Adherence Treatment Adherence 
Random Effects Estimate SE z Estimate SE z Estimate SE z 
Pediatrician  .001 .001 1.73* .004 .002 1.72* .000 .000 NS 
Practice .001 .000 1.95* .004 .002 2.72** .000 .000 NS 
Residual .012 .001 18.35*** .041 .002 18.33*** .018 .001 19.21*** 
Fixed Effects Estimate SE t Estimate SE t Estimate SE t 


















































Figure 2. Main effect of youth ADHD diagnosis on overall adherence. 
 
 Evaluation Adherence. The unconditional means model revealed that pediatricians and 
practices varied systematically in adherence with the AAP evaluation guidelines (Table 4), thus 
both random effects were included in subsequent models. The intraclass correlation coefficient 
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was .17, indicating that a large amount of the variance in adherence was due to clustering. The 
Pearson correlation between predicted and observed evaluation adherence was .48 (p < .001), 
suggesting a moderate relationship. 
 Results of the multilevel model are presented in Table 5. Wave of data collection was not a 
significant predictor and was thus not included in the final analysis. When simultaneously 
entered with fixed effects, there continued to be significant variance in evaluation adherence 
between pediatricians. Results indicate a main effect of youth diagnosis on treatment adherence 
(see Figure 3). As was the case for overall adherence, compared to youth with ADHD 
NOS/Unspecified Type, if youth were diagnosed with ADHD Inattentive Type or ADHD 
Combined Type, their pediatricians were significantly more adherent with the overall guidelines. 
The Pearson correlation between the observed and predicted adherence for the multilevel model 
was .51 (p < .001), indicating a strong relationship, and an improvement over the unconditional 






















Figure 3. Main effect of youth ADHD diagnosis on evaluation adherence. 
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 Treatment Adherence. The unconditional means model did not reveal significant variation 
between pediatricians or practices, thus random effects were not included in subsequent analyses 
and the intraclass correlation was not calculated. The Pearson correlation between predicted and 
observed treatment adherence was .15 (p < .001), which suggests a relatively weak relationship.  
 Results of the multilevel model are presented in Table 4. Results indicate a main effect for 
youth age, such that the older patients were, the less adherent physicians were with the overall 
guidelines (see Figure 4). In addition, there was a main effect of practice level perceived barriers 
(see Figure 5). Practices with higher levels of perceived barriers to providing better ADHD care 
had poorer treatment compliance than practices where fewer perceived barriers were endorsed. 
The Pearson correlation between predicted and observed treatment adherence was .16 (p < .001), 
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The present study examined the impact of pediatrician and practice knowledge and 
attitudes on adherence with the AAP ADHD guidelines using multilevel modeling. Attitudes 
toward providing psychosocial care and perceived barriers to providing better ADHD care were 
examined. Pediatrician and youth characteristics as well as wave of data collection were also 
examined as possible predictors of adherence. Overall adherence, adherence with evaluation 
guidelines, and adherence with treatment guidelines were examined in separate models.  
Results indicate that pediatricians in the present sample varied widely in their adherence 
with the AAP ADHD guidelines. No charts indicated 100% adherence across all guidelines. 
Overall adherence among the present sample (14% to 96%) had a wider range than the rates self-
reported by physicians in Rushton, Fant and Clark’s study (39% to 78%; 2004). Adherence with 
evaluation guidelines in the present study was generally higher than rates self-reported in prior 
studies (Rushton, Fanton & Clark, 2004; Chan Hopkins, Perrin, Herrerias & Homer, 2005). No 
prior studies identified examined adherence across treatment guidelines, so the findings from the 
present study provides rates against which future studies may be compared. Compared with the 
rates of adherence with specific guidelines Epstein and colleagues (2008) found with chart 
reviews, the present study had more variable adherence rates with both evaluation and treatment 
guidelines.  
There are several possible explanations for the differences between the present findings 
and the results of prior studies. These differences could represent sample to sample differences in 
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adherence. This divergence may represent the difference between objective and subjective 
reports of adherence, as self-reports may be less accurate. In addition, the present study did not 
utilize all guidelines, given that some could not easily be translated into an objective measure, so 
differences could indicate the difference in guidelines targeted.  
Results of the present study indicate that on average, pediatricians were fairly 
knowledgeable about the AAP ADHD guidelines; however there continued to be some 
variability, with some pediatricians attaining near perfect scores on the Knowledge 
Questionnaire while others appear to be lacking key knowledge about evidence-based evaluation 
and treatment of ADHD. The majority of KQ’s were completed prior to the release of the 
treatment guidelines. Thus, the present findings regarding knowledge may in part indicate a lack 
of availability of knowledge about best practices.  
The present study found that neither pediatrician nor practice-level knowledge were 
significant predictors of any of the three types of adherence. This finding contrasts with the 
results of prior research on the AAP ADHD guidelines (Lanham, 2006), which suggests that 
increased familiarity was associated with better adherence. However, research examining the 
relationship between knowledge or familiarity and adherence with other CPG’s is mixed, with 
some studies suggesting that familiarity or knowledge is associated with better adherence and 
other studies suggesting that familiarity with CPG’s is not critical for adherence.  
There are multiple possible explanations for the non-significance of knowledge as a 
predictor of adherence in the present study. First, the pediatricians in the current sample scored 
fairly high on the Knowledge Questionnaire, suggesting that they already knew the information 
covered in the guidelines. Another potential explanation is that perhaps the pediatricians in the 
present sample perceived that they “knew better” than the guidelines. That is, because they are 
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likely familiar with youth with ADHD and with evaluating and treating these youth, their actual 
practice may be based on their clinical experiences rather than on the best practice guidelines. 
Related to this, years of experience as a pediatrician may lead to variation in practice despite 
knowledge of best practices. Corresponding to the possible impact of experience, pediatricians 
may perceive themselves to have competence based on their experience, which may or may not 
be an accurate perception. Such perceptions could affect their openness to trying new or different 
practice behaviors, such as those outlined in the AAP ADHD guidelines. Thus, perhaps 
familiarity and experience—both with youth with ADHD and in terms of years of experience—
and/or pediatricians’ perception of their competence impacts the relationship between knowledge 
and adherence.  
 The present study also found that, with the exception of practice-level perceived barriers 
predicting adherence with treatment guidelines, pediatrician and practice attitudes were generally 
not significant predictors of adherence. This study is the first study identified that empirically 
examined the relationship between attitudes and adherence with the AAP ADHD guidelines. 
Research examining other CPG’s has generally shown that more negative attitudes are associated 
with poorer adherence with guidelines. 
Attitudes in the present study may have generally not predicted adherence for a variety of 
reasons. First, there may have been decreased variability in attitudes among the pediatricians 
sampled, as they had generally positive attitudes toward psychosocial care. It is likely the case 
that multiple other variables interact with attitudes to predict adherence. For example, while 
pediatricians or practices may have negative attitudes toward providing psychosocial care, their 
motivation and commitment may lead them to provide quality care despite these attitudes. Thus, 
perhaps additional pediatrician characteristics must be examined to fully understand the present 
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finding. Similarly, it could be that youth or family characteristics also play a key role in 
determining whether pediatrician attitudes predict adherence. For example, pediatricians may 
have positive attitudes toward providing psychosocial care and may be working with a patient 
with a complex presentation or whose family is unwilling or unable to follow-through with 
appointments or treatment recommendations, which could impact their adherence with 
evaluation and treatment guidelines.  
Related to measurement, the attitudes measures utilized in the present study may have 
contributed to the non-significant findings. Although both the PBQ-R and PBS-R had adequate 
psychometrics and conformed to single factor structures, both assess a variety of attitudes. This 
contrasts with the majority of prior research examining the relationship between attitudes and 
adherence, which typically assessed only one type of attitudes. Thus, perhaps by assessing 
various types of attitudes within a given measure, the relationship between relevant attitudes and 
adherence was weakened.  
Although no pediatrician level attitudes predicted adherence in the present study, higher 
practice-level perceived barriers were associated with poorer adherence with treatment 
guidelines. Examining the items endorsed by practices revealed that the most frequently cited 
barriers are external barriers, related to insufficient time, competing demands, having inadequate 
support and tools, and billing concerns. Internal barriers, such low motivation or knowledge, 
were less frequently cited by practices. This finding is consistent with the current findings that 
knowledge and attitudes are generally high in this sample. This suggests that the external barriers 
practices perceive may interfere with their adherence. 
It is possible that those practices with higher perceived barriers have a different culture or 
different approach to providing psychosocial treatment. Treating youth with ADHD can be an 
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involved process that requires multiple follow-ups, collateral contacts and modifying treatment 
over time. This work can be time consuming and may not yield high reimbursements. In 
addition, some physicians may be less inclined to work with this population, given the behavioral 
problems that often coincide with ADHD.  
While practices may screen and evaluate youth for ADHD, they may elect to refer these 
patients elsewhere for treatment based on perceived external barriers such as time, 
reimbursement, and availability of consulting mental health professions or internal barriers such 
as discomfort of office staff in dealing with patients with ADHD, lack of interest, or confusion 
about behavioral scales or treatment tools. Because of this, when patients with ADHD are treated 
by pediatricians in such practices, the pediatricians may be less able to provide care that is 
consistent with the AAP ADHD guidelines. Alternatively, it is possible that the perception of 
barriers is accurate; this would suggest that some practices have more barriers to providing better 
care and that these barriers impede the quality of treatment provided.  
Adherence rates in the present study varied depending on the type of guideline, as did the 
prediction of adherence using multilevel modeling. With respect to the prediction of adherence, 
each final model was a unique combination of random and fixed effects. This makes sense, as 
evaluation and treatment and overall management of youth with ADHD each require a different 
set of skills. Descriptively, adherence was generally higher for evaluation guidelines than 
treatment guidelines.  
These findings may be explained by the observation that the treatment guidelines are 
more complex and require more efforts than the evaluation guidelines. Although the evaluation 
guidelines indicate the need for collateral contacts, the use of assessment measures, and 
screening for comorbid conditions, which take additional time, the behavior needed to follow 
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these recommendations are fairly consistent across youth. This contrasts with the treatment 
guidelines, which may require different actions and follow-up depending on a variety of factors 
including characteristics of the youth, the youth’s response to treatment, and the family’s 
openness to and ability to try different treatments. In addition, pediatricians may be more 
experienced diagnosing ADHD than treating ADHD, since many pediatricians may do initial 
evaluations then subsequently refer youth to psychiatrists for psychopharmacology follow-up. 
Although pediatrician demographic characteristics were not significant predictors of 
adherence within the present study, youth descriptive characteristics were. In particular, youth 
age and ADHD diagnosis were both significant predictors of overall adherence, while youth 
ADHD diagnosis predicted adherence with evaluation guidelines, and youth age predicted 
adherence with treatment. With respect to youth age, physicians were less adherent overall and 
with treatment guidelines for older youth. Given that onset of ADHD symptoms is in early 
childhood, pediatricians are likely more familiar and experienced in evaluating and treating 
younger children with ADHD. In addition, the presentation of ADHD can vary across time, 
causing differences in the most prominent symptoms. Accordingly, pediatricians may be more 
comfortable with management strategies for younger children. Additional concerns may impact 
pediatrician behavior and lead to them deviating from the AAP ADHD guidelines. For example, 
because adolescents have more involvement in their own treatment, they may be less tolerant of 
multiple medication trials or of side effects, which may impact pediatrician adherence. In 
addition, pediatricians may not prescribe the recommended first-line medications, due to 
developmental changes or concerns about possible medication abuse among adolescents.  
The present findings regarding youth diagnosis significantly predicting pediatrician 
overall and evaluation adherence make sense in the context of pediatricians’ typical practice. 
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Diagnosis likely feels more straightforward for youth with ADHD Hyperactive-Impulsive Type 
than for youth with Inattentive or Combined Types. This is because children presenting with 
Hyperactive-Impulsive Type often have symptoms that are more easily observable. Because of 
this, pediatricians may be more likely to deviate from the AAP guidelines by taking short-cuts or 
skipping steps, because the child “appears” to have ADHD. Similarly, the overall process of 
managing a youth with ADHD may seem more straight-forward for youth with Hyperactive-
Impulsive Type, leading pediatricians to utilize their typical practice and not rely on the AAP 
ADHD guidelines. For youth with Inattentive or Combined Types, pediatricians may be more 
likely to want or feel like they need additional support and information obtained by following the 
guidelines, as these youth have a more complex presentation.   
There was no effect of wave of data collection on prediction of adherence, suggesting 
that time did not impact pediatricians and practices. This is notable, given that wave two charts 
were collected several years after the release of the AAP ADHD guidelines, and pediatricians 
would have potentially had ample opportunity to learn about and incorporate the guidelines into 
their practice. In addition, the lack of wave effect is important given that charts were collected 
following (or for early pre-intervention charts concurrent with) the dissemination of the AAP 
ADHD guidelines.   
 The current study was the first to use multilevel modeling to examine the relationship 
between pediatrician and practice level predictors and pediatrician adherence with the AAP 
ADHD guidelines. This analysis method ensured that systematic variation between pediatricians 
and practices was accounted for, while allowing for inspection of the effects of predictor 
variables at multiple levels. Results suggest that there is significant variation between 
pediatricians. In addition, this study was the first to examine a combination of youth, pediatrician 
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and practice level predictor variables to attempt to explain pediatrician adherence with these 
guidelines. Practice level and youth characteristics in conjunction with pediatrician clustering 
predicted adherence. However, counter to expectations, in the present study, knowledge and 
attitudes did not generally contribute to the prediction of adherence, with the exception of 
practice level perceived barriers predicting treatment adherence.   
 One limitation in the present study is related to measurement. Although utilizing chart 
audit data provided a more objective measure of adherence, not all guidelines could be included, 
which could have impacted the present results. More importantly, although the chart audit 
captures the actions pediatricians are taking that are consistent with the guidelines, it does not 
account for the actions pediatricians take that are inconsistent with the guidelines. Thus, it is be 
possible that pediatricians in the present sample are engaging in clinical practices that are not 
recommended. To this effect, several studies examining the AAP ADHD guidelines found that 
physicians frequently used response to a trial of stimulant medication to assist in evaluating 
patients for ADHD (Daly, Rasmussen, Agerter & Cha, 2006; Lanham, 2006). In addition, 
multiple studies have found that physicians routinely use other laboratory tests in evaluating 
youth for ADHD, counter to the AAP ADHD guidelines (Chan, Hopkins, Perrin, Herrerias & 
Homer, 2005; Rushton, Fant & Clark, 2002). 
 An additional measurement related concern is that although there was variation in 
attitudes scores, pediatricians in the present study had generally positive attitudes. By somewhat 
restricting the variability in attitudes, the predictive power of attitudes may have been 
constricted. It will be important to examine the attitudes of physicians in further studies, to 
determine whether their attitudes are as positive or if it is tied either to the current sample or 
measures utilized. 
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 Another limitation is related to the sample of physicians used. All studies identified 
examining the AAP ADHD guidelines target physicians in a given community, and the present 
study continues this trend. In addition, pediatricians at independent practices made up the current 
sample. These pediatricians may have different knowledge, attitudes, and practice behaviors 
from pediatricians in hospitals and academic settings. Finally, pediatricians are generally better 
at following CPG’s than family physicians, which has been documented in the general literature 
on CPG’s (e.g., Cheng et al., 1996; Pathman et al., 1996) as well as in the literature on the AAP 
ADHD guidelines (Rushton, Fant & Clark, 2002). 
Despite these limitations, the present study extends the literature on adherence guidelines 
in general and on adherence with the AAP ADHD guidelines in particular. Findings suggest that 
the sample had generally high knowledge and positive attitudes, and knowledge and attitudes 
were generally not significant predictors of adherence. The primary study’s knowledge-based 
intervention for adherence showed a non-significant effect. In addition, the dissemination of the 
guidelines alone by publishing them did not appear to change pediatrician behavior, given that 
pediatricians in the sample continued to demonstrate variable adherence well after the release of 
the guidelines. Taken together, these findings suggest that pursuing additional research on 
knowledge and attitudes may not be a helpful avenue. However, further research is needed to 
help establish what is driving physician adherence behaviors. 
The significance of practice-level perceived barriers as predictors of treatment adherence 
suggests that they are an important area to explore in future research. Further assessing 
perception and experience of barriers, particularly external barriers, may be helpful in identifying 
practices in need of support or intervention. Interventions focused on overcoming external 
barriers may be more likely to have a significant impact than those targeting knowledge and 
  44
attitudes, however it may be difficult to intervene on external barriers, given that they largely 
represent systemic issues impacting health care treatment (e.g., time for office visits, 
reimbursement rates). 
Because prediction models differed by type of adherence, different types of interventions 
may be helpful at improving overall management versus evaluation adherence versus treatment 
adherence. Targeting treatment adherence may be most beneficial, given that adherence with 
treatment guidelines was generally lower than adherence with evaluation guidelines in the 
current study as well as in prior research. Understanding which aspects of the treatment 
guidelines physicians are less adherent with would be helpful in guiding such interventions.   
The present study suggests that pediatricians may be less likely to engage in best 
practices for youth who are older or who have ADHD Hyperactive-Impulsive Type. It will be 
important to do additional research to understand the meaning of lower adherence with these 
youth. It may be helpful to provide additional supports for pediatricians, to ensure that they are 
able to provide quality services across development and diagnoses. However, this will depend on 
whether deviations from the guidelines are found to indicate problematic practices. 
Although significant prediction models were developed for each type of adherence in the 
present study, there remained a significant amount of variation in adherence that was not 
accounted for by study variables. This suggests the need for further multilevel research to fully 
understand what is contributing to pediatrician adherence. Including new predictors in these 
multilevel models, such as variables related to pediatrician experience or motivation and 
commitment to providing quality care, will help determine whether they moderate the 
relationship between knowledge or attitudes and adherence.   
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In conclusion, this study examined the relationship between pediatrician and practice 
level knowledge and attitudes and pediatrician adherence with the AAP ADHD guidelines. 
Although results did not support the relationship between knowledge and adherence, practice 
level perceived barriers to providing better ADHD care was predictive of adherence with 
treatment guidelines. In addition, youth age and diagnosis were significant predictors of 
adherence. This study highlights the importance of examining variables at each level of the data 
to help establish what contributes to pediatrician behavior. 
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Appendix A: Pediatrician Background Questionnaire 
Pediatrician Knowledge of the AAP Guidelines 
Knowledge Questionnaire 
Pediatrician Attitudes 
Perceived Barriers Questionnaire 




The following questions ask about your knowledge of best practices when evaluating and 
treating ADHD. 
 
1. How many subtypes of ADHD are there?     
 Circle only one 
One............................................. 1 
Two ............................................ 2 
Three .......................................... 3   
Four ............................................ 4 
Don’t know ................................ 88 
 
2. To be diagnosed with ADHD – hyperactive/impulsive subtype, how many positive 
symptoms must a child have? 
 Circle only one 
At least 6 of 9............................. 1 
All 9 .......................................... 2 
At least 6 of 18 .......................... 3   
At least 4 of 9 ............................ 4 
Don’t know ................................ 88 
 
3. True or false, pediatricians should screen children for the 











a. Oppositional defiant disorder   1 0 88 
b. Conduct disorder  1 0 88 
c. Anxiety disorder  1 0 88 
d. Depressive disorder 1 0 88 
e. Learning disabilities 1 0 88 
f. Language disabilities 1 0 88 
g. Tic disorders  1 0 88 
h. Pervasive developmental disorders 1 0 88 
i. Psychotic disorders  1 0 88 
j. Motor disabilities  1 0 88 
k. High lead levels  1 0 88 
l. Abnormal electrical brain activity  1 0 88 
m. Hyperthyroidism  1 0 88 
n. Bipolar disorder 1 0 88 
o. Age-appropriate behaviors in active children  1 0 88 
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a. Pediatricians should obtain information directly from classroom 







b. The DSM-IV outlines 20 symptoms that define ADHD. 1 0 88 
c.  Child must exhibit functional impairment in two or more 














a. should target improvement in core symptoms. 1 0 88 
b. should target improvement in functioning.  1 0 88 
c. needs to be monitored once the child is stabilized on medication  1 0 88 
d. should be developed with the pediatrician, parents and patient 
working together. 
1 0 88 
e. should target child’s social relationships. 1 0 88 
f. should target academic performance. 1 0 88 
g. should include educating parents about the chronic nature of 
ADHD. 
1 0 88 
6. True or false, the following behavior therapies are effective 







a. positive reinforcement. 1 0 88 
b. time out. 1 0 88 
c. response cost. 1 0 88 
d. token economy programs. 1 0 88 
7. True or false, the following are appropriate targets for 










a. completion of assignments. 1 0 88 
b. increased on-task behavior. 1 0 88 
c. diminishing disruptive behavior. 1 0 88 
d. oppositional behavior. 1 0 88 
e. conforming to home and school rules. 1 0 88 







a. can be stopped when children enter puberty. 1 0 88 
b. improve children’s functioning. 1 0 88 
c. can stunt growth. 1 0 88 
d. have a permanent effect on the brain.  1 0 88 
e. are frequently stopped because the patient develops tolerance.  1 0 88 





a. Short and long-acting methylphenidate, short- and long-acting 
Dexedrin and mixed amphetamine salts can equally be 














b. When treating with stimulants, serologic or hematological 
monitoring should be done. 1 0 88 
c. Adverse effects of stimulants are usually mild, short lived and 







d. Permanent slowing of growth velocity is a side effect when 







e. Pemoline should not be a first line treatment because of 
potential fatal hepatotoxicity. 1 0 88 
f. Desipramine and Bupropion are supported for treating ADHD 







g. During medication titration weekly feedback from parents is 
recommended. 1 0 88 
h. During medication titration weekly feedback from classroom 







i. The best dose for stimulant medication is achieved when 








j. Children who are treated with stimulants usually have the best 







k. Behavioral therapy may be needed to manage core ADHD 







l. Monitoring long-term treatment requires direct input from 
teachers. 1 0 88 
m. Since the response to medication is stable during school aged 







n. An office visit every 12 months is adequate for monitoring after 







10. True or false, during medication refills the pediatrician 







a. child’s adherence to regimen. 1 0 88 
b. medication side effects. 1 0 88 
c. improvement in targeted behaviors. 1 0 88 
d. improvement in core ADHD behaviors. 1 0 88 
e. improvement in behavior in general. 1 0 88 
f. child’s academic performance. 1 0 88 
g. child’s functioning in home. 1 0 88 
h. child’s interpersonal relationships. 1 0 88 
i. changes in child’s appetite. 1 0 88 
j. child’s weight. 1 0 88 
k. child’s height. 1 0 88 
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Perceived Barriers Questionnaire 
Over the past 12 months, how frequently did the 
following issues prevent you from providing better 
care to children who were being assessed or 

















a. Not enough time during the office visit to address 
ADHD  
0 1 2 3 4  
 
b. Other medical/behavioral conditions take 
precedence over ADHD 
0 1 2 3 4  
c. A lack of sound scientific evidence to support 
clinical decisions  
0 1 2 3 4  
d. Low reimbursement rates 0 1 2 3 4 
e. Confusion on how to bill for assessing and/or 
treating ADHD 
0 1 2 3 4 
f. Few qualified mental health providers available for 
consultations 
0 1 2 3 4  
 
g. My office staff is uncomfortable dealing with 
ADHD  
0 1 2 3 4 
h. Lack of personal/professional interest in ADHD  0 1 2 3 4 
i. Insufficient personal/professional knowledge and 
skills about ADHD  
0 1 2 3 4 
j. Confusion about how to use behavioral rating scales 0 1 2 3 4 
k. Lack of practical tools to assess ADHD  0 1 2 3 4 
l. Lack of practical tools to treat ADHD  0 1 2 3 4 
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Physician Belief Scale 
The following questions ask about your feelings when addressing children’s behavioral health 
issues in general. 
 
How much do you agree or disagree with the 
following statements about providing psychosocial 


































a. My patients and/or their parents/caregivers do not 
want me to investigate psychosocial problems.           1 2 3 4 5 
b. I cannot help patients with problems I have not 
experienced myself.                                                                                      1 2 3 4 5 
c. If I address psychosocial issues, patients will reject 
these issues and never return.                                            1 2 3 4 5 
d. Exploring psychosocial issues with the patient often 
causes me pain.                                                                                                  1 2 3 4 5 
e. Evaluating and treating psychosocial problems will 
cause me to be more overburdened than I already am.       1 2 3 4 5 
f. I feel guilty probing the psychosocial concerns of my 
patients.  1 2 3 4 5 
g. The psychosocial problems we all experience do not 
significantly influence the onset or course of disease.      1 2 3 4 5 
h. One reason I do not consider information about 
psychosocial problems is the limited time I have 
available.                      
1 2 3 4 5 
i. Patients will become more dependent on me if I raise 
psychological concerns.                                                       1 2 3 4 5 
j. There are so many issues to be investigated when 
seeing a patient that I do not always consider 
psychosocial factors.   
1 2 3 4 5 
k. Investigating issues of psychosocial problems 
decreases my efficiency. 1 2 3 4 5 
l. I cannot help a patient with a psychosocial problem 
that I have not resolved myself.                                1 2 3 4 5 
m. I focus on organic disease because I cannot treat 
psychosocial problems.                                                        1 2 3 4 5 
n. I find great satisfaction in treating psychosocial 
problems in patients in my practice.                  1 2 3 4 5 
o. I believe most psychosocial interventions are not 
effective.   1 2 3 4 5 
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Appendix B: Pediatrician Chart Audit 
Summary Chart Audit Form 
AAP ADHD Recommendations Included in Chart Audit and Rationale 
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Date of Audit: SUMMARY CHART AUDIT Auditor’s ID #:   
 
1. How many pages were copied from the chart?    
 
2. What is the date of ADHD diagnosis or start of ADHD medication?                          
 
  ____/____/____ Month /  Day /  Year  (Unknown=88)                 
 
A.  FAC Dx Start date: ____/____/_____     or   N/A   
B.  Date Copied:  ___/___/____; Mos Dx-Copy __  
 
3. Pediatrician’s Diagnosis:  
  ADHD Unspecified Subtype …………….…1 
  314.01 ADHD, Hyperactive/Impulsive……..2  
  314.00 ADHD, Inattentive…………………..3 
  314.01 ADHD, Combined………………......4  
  314.9   ADHD Not Otherwise Specified….…6 
  Other: ____________.....................................5 
 
4. What is the child’s birth date?   
___/___/___ Month /  Day /  Year  (Unknown=88)       
A.  Age at Dx:    
 
5. What is the child’s gender?   
Female...............................................................0 
Male ..................................................................1 
Unknown – not able to tell from chart………….88 
 
6. From reviewing the medical record, what is the child’s ethnicity/race?  
 Circle all that apply 
African American/Black ...................................1  
Caucasian/ White ..............................................2  
American Indian and Alaska Native .................3  
Asian .................................................................4  
Native Hawaiian or Other Pacific Islander .......5  
Other (Specify) _______ ...................................6  
Unknown- unable to tell from chart ..................8 
 
7. From reviewing the medical record, is the child of Spanish or Hispanic origin?   
Yes ....................................................................….1 
No .....................................................................….0 
Unknown – unable to tell from chart….8 
 
8. After you have reviewed the medical record, please rate the overall legibility of the materials in the chart.   
 Circle only one 
Poor (can read < 25%) ......................................0 
Challenging (can read 26% to 50%) .................1 
Fair (can read 51% to 75%) ..............................2 




























A.  Did the pediatrician document presence/absence of all 18 behavioral symptoms 
outlined in DSM-IV through interview, behavior rating scale or psycho-
educational report?   
YES NO UK 
B.  Did MD meet DSM-IV guidelines regarding symptoms?   YES NO UK 
1) Makes careless mistakes       Yes No SU  NM 10) Fidgety Yes   No   SU   NM 
2) Difficulty sustaining 
attention   Yes No SU NM 11) Unable to stay seated Yes   No   SU   NM 
3) Seems not to listen              Yes   No  SU   NM 12) Moves excessively (restless)    Yes   No   SU   NM 
4) Fails to finish tasks                Yes   No  SU   NM 13) Can not play quietly  Yes   No   SU   NM 
5) Difficulty organizing             Yes   No  SU   NM 14) “On the go” Yes   No   SU   NM 
6) Avoids tasks requiring 
sustained attention                 Yes   No  SU   NM 15) Talks excessively  Yes   No   SU   NM 
7) Loses things                           Yes   No  SU   NM 16) Blurts out answers  Yes   No   SU   NM 
8) Easily distracted                     Yes   No  SU   NM 17) Difficulty awaiting turn  Yes   No   SU   NM 
9) Forgetful                                Yes   No  SU   NM 18) Interrupts/intrudes upon others  Yes   No   SU   NM 
C.  Scales used, but not included___________________________________ 
D.  Functional impairment in at least two settings  TP YES NO 
Impaired functioning in home setting?   Yes No NM 
Impaired functioning in school setting? Yes No NM 
Impaired functioning in other setting?   Yes No NM 
Need 2 
of 3 } 
Impaired functioning in MD office or during psych 
evaluation?   Yes No NM 
  
Impaired functioning in unspecified setting?    Yes No   
E.  Were impairing behavioral symptoms present 
before the age of 7 years?   TP   YES NO  N/M 
F.  Were impairing behavioral symptoms present for 
at least 6 months before diagnosis/treatment? 
TP    
YES NO N/M 
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10. Evaluation/Diagnosis phase: Pediatricians should obtain information about the DSM-IV criteria directly 














A. Any information relevant to DSM-IV criteria collected 
directly from family?    YES NO UK* 
1) Does medical record contain written communication (letter, 
email, note, behavior rating scale, forms, behavior report 







K   
OR 
2) Does medical record contain verbal communication with 
parent/caregiver/family (phone call, attending meeting)?   Yes 
c)
o d) OR 
3) Other (Describe)_____________________________ Yes e) o 
f) 
K g) 
B. Any information relevant to DSM-IV criteria collected from 
classroom teacher?  N/A YES NO UK* 
1) Does medical record contain written communication (letter, 
email, note, behavior rating scale, forms, behavior report 




2) Does medical record contain verbal communication with 
teacher (phone call, attending meeting)?  Yes 
i)
o N/A  OR 
3) Does medical record contain copy of grades or sample of 





4) Other (Describe)  ____________________________ Yes k)o N/A 
U
K OR 
C. Pediatrician considers information from other professionals (e.g., 
school counselor, nurse) and/or psycho-educational testing when 
evaluating children for ADHD. 
YES NO 
1) Medical record contains unstructured written communication 
from professional other than classroom teacher 
(psychologist, counselor, nurse, etc.)  
Yes l) No OR 
2) Medical record contains structured written communication 
(report, scales, form, etc.) from professional other than 
classroom teacher?  
Yes m) No OR 
3) Medical record contains documentation about verbal 
communication (phone call, attending meeting) with 
professional other than classroom teacher?  
Yes n) No OR 
4) Other (Describe)  _______________________________ Yes o) No  
D.   Any information relevant to DSM-IV criteria collected from 
someone not included in 10A-C? YES NO  
Describe______________________________________________________ 
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11. Evaluation/Diagnosis phase: Pediatricians should screen children for common co-morbid conditions and 




















A. Documentation indicates pediatrician screened for any alternative 
explanations for the ADHD symptoms (Pervasive developmental disorder, 
hearing or vision problems, psychotic disorder, motor disabilities, family 
violence, age-appropriate behaviors in active children)   
Yes No UK* 
B. Documentation indicates pediatricians may screen for co-morbid conditions 
(ODD, CD, Anxiety, Depressive disorder, Learning disabilities, Language 
disabilities, Tics)with behavioral rating scales or structured/semi-structured 
interviews that focus on DSM-IV criteria for the co-morbid conditions.  
Yes NO 
1) Medical record contains behavior-rating scale(s) that screens for behaviors 
associated with co-morbid conditions.   Yes No 
O
2) Medical record contains documentation about co-morbid conditions   Yes No 
O
3) Medical record contains report(s) from other professional (psychologist, 
counselor, behavioral developmental pediatrician, or psychiatrist) that 
indicates co-morbid conditions have been screened for.    
Yes No 
O
4) Medical record indicates the school has evaluated for co-morbid conditions  Yes No  
 
 
C. Pediatricians should consider referring child to mental health clinician if 
child exhibits co-morbid conditions and/or differential diagnosis is a complex 
process 
 
1) Child referred to mental health specialist   Yes No  
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12. Treatment phase: The clinician should recommend stimulant medication and/or behavior therapy, as 
appropriate, to improve target outcomes in children with ADHD (if more than 3 ADHD meds, use an 












A. Does documentation indicate physician/staff prescribed/ 
provided behavior therapy?   Yes No 
B. Does documentation indicate child taking stimulant 
medication? (if no, skip to #13)   Yes No 
Medication 1: ________ Start date: _______  
Stop date: _______ PRN? ________ 
Is there 
Med 1?  Yes No 
C1) Documentation indicates side effects were screened for   Yes No NA  
C2) Documentation indicates side effects were present                     Yes No NA 
C3) Documentation indicates functioning/ADHD behaviors were 
screened          Yes No NA 
C4) Documentation indicates improvement in functioning/ 
ADHD behaviors Mixed Yes No NA 
C5) Documentation indicates dosage/frequency was changed 









Medication 2: ________ Start date: _______  
Stop date: _______ PRN? ________ 
Is there 
Med 2?  YES NO 
D1) Documentation indicates side effects were screened for              Yes No NA 
D2) Documentation indicates side effects were present                      Yes No NA 
D3) Documentation indicates functioning/ADHD behaviors were 
screened           Yes No NA 
D4) Documentation indicates improvement in functioning/ADHD 
behaviors       Mixed Yes No NA 
D5) Documentation indicates dosage/frequency was changed 








Medication 3: ________ Start date: _______  
Stop date: _______ PRN? ________ 
Is there 
Med 3?  YES NO 
E1) Documentation indicates side effects were screened for   Yes No NA 
E2) Documentation indicates side effects were present                      Yes No NA 
E3) Documentation indicates functioning/ADHD behaviors were 
screened             Yes No NA 
E4) Documentation indicates improvement in functioning/ADHD 
behaviors         Mixed Yes No NA 
E5) Documentation indicates dosage/frequency was changed 









13. Treatment phase: Primary care clinicians should establish a management program that recognizes 






















































Provide care consistent with the principles of any 
chronic condition     YES NO 
1) Documentation indicates MD/staff assessed family’s 
knowledge of ADHD on a date after diagnosis and/or 
beginning of treatment.                    
Yes No 
AND 
2) Documentation indicates MD/staff counseled any 
family member about their response to child’s 
condition.                                                     
Yes No 
AND 
3) Documentation indicates MD/staff educated child 
about ADHD on a date after diagnosis and/or start of 
treatment (e.g., stimulants, therapy).  
Yes No 
AND 
4) Documentation indicates MD/family set specific 
treatment goals.   Yes No AND 
5) Documentation indicates MD/staff provided families 
with information on how to contact support 





Providing the family with information on the etiology 
of ADHD, treatment, long-term outcomes, and 
effects on daily life and family activities.   
   YES NO 
1) Documentation indicates any family member (e.g. 
parents, siblings, child) educated about the causes of 
ADHD on a date after the diagnosis of ADHD and/or 
start of stimulant medication?   
Yes No 
OR 
2) Documentation indicates any family member 
educated about treatments (stimulant medication, 
therapy, classroom modifications, etc.) for ADHD.   
Yes No 
OR 
3) Documentation indicates any family member 
educated about the effects of ADHD on child’s daily 
life activities (can incl. info related to school).   
Yes No 
OR 
4) Documentation indicates any family member 
educated about the effects of child’s ADHD 
behaviors on family activities.   




14. Treatment phase: The clinician should periodically provide a systematic follow-up for the child with 
ADHD. Monitoring should be directed to target outcomes and adverse effects by obtaining specific 






















































A.  Monitoring efforts are documented   YES NO 
1) Documentation shows monitoring of at least one 
behavior targeted for treatment.   Yes No N/A 
2) Documentation contains information about child’s 
school functioning   Yes No AND 
3) Documentation indicates child’s functioning and/or 
presence/absence of 18 ADHD behavioral 
symptoms were evaluated at least once after 
diagnosis.   
Yes No AND 
4) Documentation outlines medication name, dosage, 
and frequency of administration.   Yes No NA 
5) Documentation indicates side effects were evaluated 
at least once after stimulants started.   Yes No NA 
 
} 
B. Monitoring should include a system for communication among parent, 
child and clinician with periodic direct contact with teacher or other school 
personnel before follow-up visit.   
YES NO 
1) Documentation indicates communication (e.g., 
letters, scales, in office visit, phone calls) w/ parents 
at least once since ADHD diagnosis and/or start of 
treatment.  
Yes No AND 
2) Documentation contains communication with child 
at least once since ADHD diagnosis and/or start of 
treatment.  
Yes No AND 
3) Documentation contains communication with 
classroom teacher at least once since diagnosis 
and/or start of treatment.  
Yes No OR 
4) Documentation contains communication with other 
school personnel besides classroom teacher at least 
once since diagnosis and/or start of treatment. 
       
Yes No  
 
} 
C. Monitoring plan should consider normal 
developmental changes in behavior over time, 
educational expectations, and dynamic nature of 
child’s school and home environments   
   YES NO 
1) Documentation indicates MD/staff knew child’s 
grade level after ADHD diagnosis and/or start of 
treatment   
Yes No OR 
2) Documentation indicates MD/staff asked about 
changes in child’s school or home environment at 
least once after ADHD diagnosis and/or start of 
stimulant medication.  





14. Treatment phase: The clinician should periodically provide a systematic follow-up for the child with 
ADHD. Monitoring should be directed to target outcomes and adverse effects by obtaining specific 




















































D. Once child is stable an office visit every 3 to 6 months 
allows for assessment of learning and behavior.     NA YES NO 
1) Documentation indicates MD/staff evaluated weight 
AND height and/or growth velocity at least every 6 
months since start of medication treatment for 
ADHD.  
Yes No NA AND 
2) Documentation indicates MD/staff evaluated 
functioning in school at least every 6 months since 
ADHD diagnosis and/or start of treatment   
Yes No NA AND 
3) Documentation indicates MD/staff evaluated 
interpersonal relationships at least every 6 months 
since ADHD diagnosed and/or start of treatment   
Yes No NA AND 
4) Documentation indicates MD/staff obtained updates 
from school personnel at least every 6 months since 
ADHD diagnosis and/or start of treatment.  
Yes No NA  
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AAP ADHD Guidelines and PPP 
 
 
 AAP Assessment and Diagnosis Recommendation Included in Chart Audit? Rationale 
1 
In a child 6 to 12 years old who presents with 
inattention, hyperactivity, impulsivity, academic 
underachievement, or behavior problems, primary care 
clinicians should initiate an evaluation for ADHD. 
NO Not suitable for current sample 
2 The diagnosis of ADHD requires that a child meet DSM-IV criteria. YES  
3 
The assessment of ADHD requires evidence directly 
obtained from parents or caregivers regarding the core 
symptoms of ADHD in various settings, the age of 
onset, duration of symptoms, and degree of functional 
impairment. 
YES  
3a Use of these (parent-report ADHD-specific) scales is a clinical option when evaluating a child for ADHD. YES  
3b 
Use of (parent-report) broad-band scales is not 
recommended in the diagnosis of ADHD, although 












The assessment of ADHD requires evidence directly 
obtained from the classroom teacher (or other school 
professional) regarding the core symptoms of ADHD, 
the duration of symptoms, the degree of functional 
impairment, and the coexisting conditions. A 
physician should review any reports from a school-
based multidisciplinary evaluation where they exist, 
which will include assessments from the teacher or 
other school-based professional. 
YES  
4a Use of these (teacher-report ADHD-specific) scales is a clinical option when diagnosing a child for ADHD. YES  
4b 
Use of teacher global questionnaires and rating scales 
is not recommended for the diagnosis of ADHD, 
although they maybe useful for other purposes. 
  
5 Evaluation of the child with ADHD should include assessment for coexisting conditions. YES  





not understand the 







AAP ADHD Guidelines 
 
 
 AAP Treatment Recommendation Included in Chart Audit? Explanation 
1 
Primary care clinicians should establish a 
management program that recognizes 
ADHD as a chronic condition. 
YES  
2 
The treating clinician, parents, and the 
child, in collaboration with school 
personnel, should specify appropriate 
target outcomes to guide management. 
YES  
3 
The clinician should recommend 
stimulant medication and/or behavior 
therapy, as appropriate, to improve target 




treatment plan or 
treatment 
 





when stimulants are 
used, establishing 
whether they titrate) 
3a 
For children on stimulants, if one 
stimulant does not work at the highest 




When selected management for a child 
with ADHD has not met target outcomes, 
clinicians should evaluate original 
diagnosis, use all appropriate treatments, 
adherence to the treatment plan, and 
presence of coexisting conditions. 
NO 
Difficult to determine 
when child is not 
meeting outcomes 
and the re-evaluation 
process 
5 
The clinician should periodically provide 
a systematic follow-up for the child with 
ADHD. Monitoring should be directed to 
target outcomes and adverse effects by 
obtaining specific information from 




Appendix C: Power Analysis 
 
Description of Power Analysis 




 Because the data are nested and multilevel modeling (MLM) was used to analyze the 
data, a Cohen-based power analysis would likely yield an inaccurate estimate of the power. 
Thus, the Optimal Design software for longitudinal and multilevel data was used to obtain a 
power estimate (Spybrook, Raudenbush, Liu & Congdon, 2006). Since the data are from an 
existing data set on which preliminary analyses were conducted, intraclass correlations (ICC’s) 
for the physician (ICC = .07) and practice (ICC = .14) were available (Lambert, 2006). Using the 
ICC’s, the cluster size (number of charts per physician = 10), the number of clusters per site 
(number of physicians per site = 4) and the number of sites (number of practices = 22), the power 
was calculated. Cohen’s recommended power of .80 was used, to attempt to balance Type I and 
Type II errors (Cohen, 1992).  
As shown in Figure 1, the minimum detectable effect at .80 power is about 0.44. 
Following Raudenbush’s practice (personal communication, March 27, 2006), an additional 
power calculation was conducted, estimating additional covariate that explains 60% of variation 
within the outcome. Based on this analysis, the minimum detectable effect at .80 power is about 
0.37. These power calculations represent best and worst case scenarios and suggest that the 
present study has adequate power to detect a small-to-medium sized effect. Given this, the main 



















1.0 α = 0.050   
n = 10   
J = 4   
K = 22   




Figure 1. Power analysis for the present study. 
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Appendix D: Distribution of Adherence Scores 
 
Figure 2: Overall adherence with AAP ADHD guidelines across charts 
Figure 3: Adherence with AAP ADHD evaluation guidelines across charts 
Figure 4: Adherence with AAP ADHD treatment guidelines across charts 
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Overall Adherence  
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